Is INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Halal?

NASDAQ Healthcare United States $717M
✗ NOT HALAL
Confidence: 90/100
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 268.1% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. INTEGRA LIFESCIENCES HOLDINGS CORP operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 268.1%
/ 30%
34.8%
/ 30%
36.8%
/ 30%
1.13%
/ 5%
✗ NOT HALAL
DJIM 268.1%
/ 33%
34.8%
/ 33%
36.8%
/ 33%
1.13%
/ 5%
✗ NOT HALAL
MSCI 56.4%
/ 33%
7.3%
/ 33%
7.7%
/ 33%
1.13%
/ 5%
✗ NOT HALAL
S&P 268.1%
/ 33%
34.8%
/ 33%
36.8%
/ 33%
1.13%
/ 5%
✗ NOT HALAL
FTSE 56.4%
/ 33%
7.3%
/ 33%
7.7%
/ 50%
1.13%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-6.74
P/B Ratio
0.7
EV/EBITDA
8.4
EV: $2.5B
Revenue
$1.6B
Growth: -1.7%
Beta
1.0
Average volatility
Current Ratio
2.5

Profitability

Gross Margin 56.2%
Operating Margin 12.4%
Net Margin -31.6%
Return on Equity (ROE) -39.9%
Return on Assets (ROA) 2.4%

Cash Flow & Balance Sheet

Operating Cash Flow$50M
Free Cash Flow-$45M
Total Debt$2.0B
Debt-to-Equity195.0
Current Ratio2.5
Total Assets$3.6B

Price & Trading

Last Close$9.38
50-Day MA$10.70
200-Day MA$12.68
Avg Volume764K
Beta1.0
52-Week Range
$8.70
$22.27

About INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

CEO
Ms. Mojdeh Poul
Employees
4,427
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$717M
Currency
USD

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is INTEGRA LIFESCIENCES HOLDINGS CORP (IART) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), INTEGRA LIFESCIENCES HOLDINGS CORP is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is INTEGRA LIFESCIENCES HOLDINGS CORP's debt ratio?

INTEGRA LIFESCIENCES HOLDINGS CORP's debt ratio is 268.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 56.4%.

What are INTEGRA LIFESCIENCES HOLDINGS CORP's key financial metrics?

INTEGRA LIFESCIENCES HOLDINGS CORP has a market capitalization of $717M, and revenue of $1.6B. The company maintains a gross margin of 56.2% and a net margin of -31.6%. Return on equity stands at -39.9%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.